Consolidated Statement Of Cash Flows

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. - Filing #7587509

Concept As at
2022-09-30
2022-04-01 to
2022-09-30
As at
2022-03-31
As at
2021-09-30
2021-04-01 to
2021-09-30
As at
2021-03-31
Consolidated statement of cash flows
Statement of cash flows
Cash flows from operating activities
Subtotal
2,970,633,000 JPY
2,312,902,000 JPY
Interest and dividends received
610,291,000 JPY
1,973,000 JPY
Interest paid
-63,614,000 JPY
-64,197,000 JPY
Income taxes paid
-725,203,000 JPY
-676,662,000 JPY
Net cash provided by (used in) operating activities
2,792,106,000 JPY
1,574,015,000 JPY
Cash flows from investing activities
Purchase of property, plant and equipment
-1,842,168,000 JPY
-696,295,000 JPY
Proceeds from sale of property, plant and equipment
675,000 JPY
353,000 JPY
Net cash provided by (used in) investing activities
-2,579,651,000 JPY
380,652,000 JPY
Purchase of investment securities
-1,157,494,000 JPY
-390,935,000 JPY
Purchase of shares of subsidiaries resulting in change in scope of consolidation
-1,937,239,000 JPY
JPY
Proceeds from sale of shares of subsidiaries resulting in change in scope of consolidation
JPY
1,084,650,000 JPY
Proceeds from collection of loans receivable
-10,000 JPY
342,505,000 JPY
Other, net
-51,328,000 JPY
-3,753,000 JPY
Cash flows from financing activities
Purchase of treasury shares
-284,000 JPY
-2,000 JPY
Proceeds from long-term borrowings
10,150,000,000 JPY
JPY
Dividends paid
-1,655,637,000 JPY
-825,608,000 JPY
Repayments of long-term borrowings
-1,717,844,000 JPY
-1,998,805,000 JPY
Net cash provided by (used in) financing activities
6,270,035,000 JPY
-2,921,313,000 JPY
Other, net
JPY
-2,950,000 JPY
Effect of exchange rate change on cash and cash equivalents
769,055,000 JPY
89,619,000 JPY
Net increase (decrease) in cash and cash equivalents
7,251,545,000 JPY
-877,026,000 JPY
Cash and cash equivalents
11,798,102,000 JPY
4,548,792,000 JPY
6,402,809,000 JPY
7,279,835,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.